Portland, OR, Jan. 09, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global proteomics market garnered $23.6 billion in 2021, and is estimated to generate $98.1 billion by 2031, manifesting a CAGR of 15.2% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market.
Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/1677
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $23.6 billion |
| Market Size in 2031 | $98.1 billion |
| CAGR | 15.2% |
| No. of Pages in Report | 253 |
| Segments covered | Component, Application, and Region. |
| Drivers | Surge in demand for personalized medicines |
| Rise in the number of advanced diagnostics tools in targeted disease diagnosis & treatment | |
| Increasing focus on product usage in drug designing, biomarker discoveries, and clinical diagnostics for the diagnosis and treatment of diseases | |
| Rise in the prevalence of cancer and chronic diseases. | |
| Opportunities | Increase in the number of R&D activities in the field of proteomics |
| Enhanced healthcare services | |
| Significant investments by the government to improve healthcare infrastructure | |
| Restraints | High cost |
Covid-19 Scenario:
- The outbreak of the COVID-19 pandemic had a negative impact on the growth of the global proteomics market, owing to increased demand for proteomics services during the lockdown.
- Moreover, the market is anticipated to witness steady growth in the post-pandemic and will grow at a significant CAGR during the forecast period. This is attributed to the increase in the adoption of personalized medicines for the treatment of many diseases as well as an increase in technological advancement in the field of proteomics.
The research provides detailed segmentation of the global proteomics market based on component, application, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/1677
Based on component, the reagents segment held the highest share in 2021, accounting for nearly four-fifths of the global proteomics market, and is expected to continue its leadership status during the forecast period. In addition, the same segment is expected to register the highest CAGR of 15.5% from 2022 to 2031.
Based on application, the drug discovery segment accounted for the highest share in 2021, contributing to around three-fifths of the global proteomics market, and is expected to maintain its lead in terms of revenue during the forecast period. In addition, the same segment is expected to manifest the highest CAGR of 15.8% from 2022 to 2031.
Based on region, North America held the largest share in 2021, contributing to nearly two-fifths of the global proteomics market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 18.0% during the forecast period.
Leading market players of the global proteomics market analyzed in the research include Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, Bio-Rad Laboratories Inc, Agilent Technologies Inc., Li-Cor Inc, Bruker Corporation, Perkin Elmer Inc, Danaher Corporation, Horiba Ltd.
The report provides a detailed analysis of these key players of the global proteomics market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Trending Reports in Healthcare Industry:
Biomarkers Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Male Infertility Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Biosimilars Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Synthetic Biology Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Medical/Diagnostic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Dialysis Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
